J4 ›› 2012, Vol. 38 ›› Issue (2): 303-307.

• 临床研究 • 上一篇    下一篇

组蛋白乙酰化酶hMOF在肾透明细胞癌组织中的表达及其临床意义

迟长亮1|芦志华1|管旌旌1|王 勇2|唐宇哲1|蔡 勇3|金景姬3|王春喜1   

  1. 1.吉林大学第一医院泌尿外科|吉林 长春 130021;2.吉林省人民医院泌尿外科|吉林 长春 130021; 3.吉林大学生命科学学院表观遗传学实验室|吉林 长春 130012
  • 收稿日期:2011-09-28 出版日期:2012-03-28 发布日期:2012-03-28
  • 通讯作者: 王春喜(Tel:0431-88782321,E-mail:chunxi_wang@126.com) E-mail:chunxi_wang@126.com
  • 作者简介:迟长亮(1985-)|男|吉林省长春市人|在读医学硕士|主要从事泌尿系统肿瘤及表观遗传学领域的研究。
  • 基金资助:

     国家自然科学基金资助课题(31070668)

Expression of hMOF histone acetyltransferase in clear cell renal cell carcinoma tissue and its clinical significance

CHI Chang-liang1,LU Zhi-hua1|GUAN Jing-jing1|WANG Yong2,TANG Yu-zhe1,CAI Yong3,JIN Jing-ji3,WANG Chun-xi1   

  1. 1.Department of Urinary Surgery,First Hospital,Jilin University,Changchun 130021,China;2.Department of Urinary Surgery,Jilin Province People’s Hospital,Changchun 130021,China;3.Epigenetics Laboratory,College of Life Science,Jilin University,Changchun 130012,China
  • Received:2011-09-28 Online:2012-03-28 Published:2012-03-28

摘要:

目的:检测组蛋白乙酰化酶hMOF蛋白在肾透明细胞癌(RCC)组织中的表达,探讨其与肾癌患者临床病理特征的关系。方法:采用免疫组织化学、qRT-PCR方法检测正常肾组织与肾癌组织中hMOF的表达,分析hMOF表达与肾癌患者临床病理特征的关系。结果:qRT-PCR结果显示,9例肾癌患者中有4例(44.4%)hMOF的mRNA水平显著下降。免疫组织化学结果显示,39例(62.1%,39/66)肾癌组织中hMOF蛋白表达为阴性或弱阳性,而癌旁正常组织仅4例(6.1%,4/66) hMOF蛋白的表达为阴性或弱阳性,2组比较差异有统计学意义(P<0.05)。其中肾癌组织FuhrmanⅢ 中hMOF表达明显低于FuhrmanⅠ~Ⅱ,差异有统计学意义(P<0.05)。中低分化肾癌组织hMOF表达明显低于高分化组,差异有统计学意义(P<0.05)。hMOF蛋白表达水平降低的肾癌患者其区域淋巴结及远处器官转移的风险增高。结论:hMOF蛋白在肾癌组织、尤其病理分期及Fuhrman分级增高的肾癌组织中的表达显著下降,提示hMOF蛋白可能与肾癌的发生、发展及恶性程度有关。

关键词:  hMOF;肾肿瘤;免疫组织化学;实时定量聚合酶链反应

Abstract:

Objective
To detect the hMOF protein expression in renal cell carcinoma(RCC) tissue,and explore its relationship with the cliniopathological characteristics of kidney carcinoma.Methods Immunohistochemistry and qRT-PCR were used  to detect the hMOF expression in the normal kidney tissues and renal cell carcinoma tissues.The relationship between the hMOF expression and clinical features of kidney carcinoma  was analyzed.Results The  qRT-PCR results showed that there were 4 cases in 9 cases of RCC (44.4%) which hMOF mRNA levels were decreased significantly.The immunohistochemistry results showed that there were 39 cases (62.1%,39/66) of RCC  which hMOF protein expression was negative or weakly positive,only 4 cases (6.1%,4/66) of normal kidney tissues which hMOF protein expression was negative or weakly positive,there was significant difference between two groups (P<0.05). The hMOF expression  in Fuhrman Ⅲ kidney carcinoma tissues  was significantly lower than that in Fuhrman Ⅰ-Ⅱ(P<0.05),and it was significantly lower in poorly and moderately differentiated RCC tissues  than that in well differentiated group(P<0.05).In addition,in hMOF lower expression group,the risk of lymphonode and distant metastasis was increased.Conclusion With the increasing of Fuhrman grade,the expression of hMOF protein in kidney carcinoma  tissue is decreased significantly.The hMOF protein may be associated with the occurrence and development of kidney carcinoma,and malignant degree.

Key words: hMOF;renal cell carcinoma;immunohistochemisry;quantive , real time-polymerase chain reaction

中图分类号: 

  • R737.11